A new multicenter trial has used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide. A first ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...
Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results